These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35760713)

  • 1. A Qualitative Investigation of Older Adults' Conceptualization of Quality of Life and a Think-Aloud Content Validation of the EQ-5D-5L, SF-12v2, Warwick Edinburgh Mental Wellbeing Scale, and Office of National Statistics-4.
    Penton H; Dayson C; Hulme C; Young T
    Value Health; 2022 Dec; 25(12):2017-2027. PubMed ID: 35760713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content validity of the EQ-5D-5L with skin irritation and self-confidence bolt-ons in patients with atopic dermatitis: a qualitative think-aloud study.
    Szlávicz E; Szabó Á; Kinyó Á; Szeiffert A; Bancsók T; Brodszky V; Gyulai R; Rencz F
    Qual Life Res; 2024 Jan; 33(1):101-111. PubMed ID: 37787930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do older adults receiving aged care services understand and respond to the EQ-5D-5L? A think-aloud study in residential care.
    Lay K; Crocker M; Engel L; Ratcliffe J; Charlton S; Hutchinson C
    Qual Life Res; 2023 Nov; 32(11):3161-3170. PubMed ID: 37386266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis.
    Rencz F; Mukuria C; Bató A; Poór AK; Finch AP
    Qual Life Res; 2022 Oct; 31(10):3049-3060. PubMed ID: 35471487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response process validity of three patient reported outcome measures for people requiring kidney care: a think-aloud study using the EQ-5D-5L, ICECAP-A and ICECAP-O.
    Mitchell PM; Caskey FJ; Scott J; Sanghera S; Coast J
    BMJ Open; 2020 May; 10(5):e034569. PubMed ID: 32414822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Well Does the EQ-5D-Y-5L Describe Children With Intellectual Disability?: "There's a Lot More to My Child Than That She Can't Wash or Dress Herself.".
    Blackmore AM; Mulhern B; Norman R; Reddihough D; Choong CS; Jacoby P; Downs J
    Value Health; 2024 Feb; 27(2):190-198. PubMed ID: 38043713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective.
    Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D
    Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes.
    Matza LS; Boye KS; Stewart KD; Curtis BH; Reaney M; Landrian AS
    Health Qual Life Outcomes; 2015 Dec; 13():192. PubMed ID: 26627874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires.
    Sawada A; Hiragi S; Tamura H; Goto R; Matsuyama Y; Sakai K; Miyata H; Yanagita M; Kuroda T; Ogawa O; Kobayashi T
    Transplant Proc; 2021 Apr; 53(3):881-884. PubMed ID: 33303208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where's WALY? : A proof of concept study of the 'wellbeing adjusted life year' using secondary analysis of cross-sectional survey data.
    Johnson R; Jenkinson D; Stinton C; Taylor-Phillips S; Madan J; Stewart-Brown S; Clarke A
    Health Qual Life Outcomes; 2016 Sep; 14(1):126. PubMed ID: 27608769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases.
    Sakthong P; Munpan W
    Appl Health Econ Health Policy; 2017 Oct; 15(5):669-679. PubMed ID: 28290106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative exploration of the content and face validity of preference-based measures within the context of dementia.
    Engel L; Bucholc J; Mihalopoulos C; Mulhern B; Ratcliffe J; Yates M; Hanna L
    Health Qual Life Outcomes; 2020 Jun; 18(1):178. PubMed ID: 32527264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.
    Kangwanrattanakul K; Parmontree P
    Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Validation Study of the EQ-5D-5L and ICEpop Capability Measure for Older People Among Older Individuals With Depressive Symptoms in Brazil.
    Nakamura CA; Mitchell PM; Peters TJ; Moreno-Agostino D; Araya R; Scazufca M; Hollingworth W
    Value Health Reg Issues; 2022 Jul; 30():91-99. PubMed ID: 35325703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis.
    Chuang LH; Cohen AT; Agnelli G; Gumbs PD; Bauersachs R; Kroep S; Gitt AK; Monreal M; Willich SN; van Hout B
    Qual Life Res; 2019 May; 28(5):1155-1177. PubMed ID: 30607785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Feasibility and Validity of Preference-Based Quality of Life Measures With Informal Carers: A Think-Aloud Study.
    McLoughlin C; Goranitis I; Al-Janabi H
    Value Health; 2023 Nov; 26(11):1655-1664. PubMed ID: 37516197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.